Oral Health Resource Center

Click on the subcategory below to find drug monographs for that particular area.

FDA: Oral Viscous Lidocaine Warning

The FDA warns that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain.

MC3 for RA, Periodontitis

Melanocortin receptor type 3 (MC3) has protective properties for joint and periodontal tissues.

Rebuilding Teeth with Laser Therapy

Non-ionizing, low-power laser (LPL) treatment may be coming to a dentist office near you in the future.

Periodontitis Tied to RA

Periodontitis is independently associated with established seropositive rheumatoid arthritis (RA).

Methemoglobinemia, Benzocaine Warning

The FDA will allow manufacturers of OTC oral health care products containing benzocaine to include a product label warning on methemoglobinemia.

Primary Care for Cavity Prevention

The USPSTF has issued recommendations for prevention of dental caries in children by primary care clinicians.

Smart Devices for Smarter Health

A new generation of smart devices look to monitoring vital signs and activities, including dental care.

Coupons and Patient Assistance

Pass along free prescription and OTC drug coupons, vouchers, and rebates to help reduce your patients' healthcare costs.

News

Melanocortin Receptor Agonist Can Treat RA, Periodontal Disease

Melanocortin receptor type 3 (MC3) has protective properties for joint and periodontal tissues, according to a new study.

Oral Viscous Lidocaine Not For Teething Pain, Warns FDA

The FDA has issued a warning that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain, and that OTC topical medications may also be harmful and should not be used.

Periodontitis Independently Tied to RA

Periodontitis (PD) is independently associated with established seropositive rheumatoid arthritis (RA).

Methemoglobinemia Warning OK'd for Benzocaine Products

The FDA announced that it will allow manufacturers of OTC oral health care products containing benzocaine to include a product label warning regarding the risks of methemoglobinemia associated with these products.

Featured courses from mycme

SCOPE of Pain: Safe and Competent Opioid Prescribing EducationExternal web site

SCOPE of Pain is an educational program that helps you safely and competently manage your ...

CME|CE 3.00 Credits

Accelerated cardiovascular disease; Oral health during pregnancyExternal web site

This activity is taken from the December 2012 issue of JAAPA. It includes the CME ...

CME 1.00 Credits

Maximizing oral health in children; Vasculitis: Diagnosis and treatmentExternal web site

This activity is taken from the July 2012 issue of JAAPA. It includes the CME ...

1.00 Credits

Sign Up for Free e-newsletters